A5 Laboratories Announces Relocation of Facilities Into Biotechnology Research Institute in Montreal
June 28, 2011 09:13 ET
|
A5 Laboratories, Inc.
MONTREAL, June 28, 2011 (GLOBE NEWSWIRE) -- A5 Laboratories Inc., (OTCBB:AFLB) - a Biotechnology company by developing novel immune therapeutic applications of interferon therapy to treat cancer and...
Bovine Interferon Production Initiated by A5 Laboratories Inc.
May 09, 2011 14:31 ET
|
A5 Laboratories, Inc.
MONTREAL, May 9, 2011 (GLOBE NEWSWIRE) -- A5 Laboratories Inc. (OTCBB:AFLB), a Biotechnology company, by developing novel immune therapeutic applications of interferon therapy to treat cancer and...
A5 Laboratories Inc. Retains Premier Media Services, Inc. to Lead Investor and Public Relations Efforts
March 28, 2011 13:04 ET
|
A5 Laboratories, Inc.
MONTREAL, March 28, 2011 (GLOBE NEWSWIRE) -- A5 Laboratories Inc. (OTCBB:AFLB), a biotechnology company by developing novel immune therapeutic applications of natural gamma-interferon therapy to treat...